Left ventricular extracellular volume expansion is not associated with atrial fibrillation or atrial fibrillation– Mediated left ventricular systolic dysfunction

Suvai Gunasekaran, Daniel C. Lee, Bradley P. Knight, Lexiaozi Fan, Jeremy D. Collins, Kelvin Chow, James C. Carr, Rod Passman, Daniel Kim*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Purpose: To determine whether left ventricular (LV) extracellular volume (ECV) expansion is associated with atrial fibrillation (AF) or AF-mediated LV systolic dysfunction (LVSD) while minimizing the influence of biologic and imaging methodologic confounders. Materials and Methods: This study examined the prevalence of LV ECV expansion in 137 patients with AF (mean age, 62 years ± 11 [standard deviation]; 92 male patients and 45 female patients; 83 paroxysmal and 54 persistent) who underwent preablation cardiovascular MRI. Biologic confounders were minimized by measuring the ECV fraction and excluding patients with severe LV hypertrophy, defined as wall thickness greater than 1.5 cm. Imaging confounders were minimized by using an arrhythmia-insensitive-rapid (AIR) cardiac T1 mapping pulse sequence. Other cardiac functional parameters, including LV ejection fraction (LVEF) and left atrial end-diastolic volume indexed to body surface area, were assessed using cine cardiovascular MRI. A substudy was conducted in 32 patients with no AF (mean age, 54 years ± 16) in sinus rhythm to establish control values and convert these values between the AIR sequence and literature-based modified Look-Locker inversion recovery (MOLLI) values. Results: The mean ECV was not significantly different (P > .05) between patients with AF with a normal LVEF (24.5% ± 2.8; n = 107), patients with AF with LVSD (24.5% ± 2.5; n = 30), and patients with no AF (24.4% ± 3.8; n = 32), but there was a significant interaction between ECV and CHA2 DS2-VASc score (P = .045). Compared with the literature data obtained from healthy control patients scanned using MOLLI, 99.3% of patients with AF had ECV below the fibrosis cutoff point (32.8% when converted from MOLLI T1 mapping to AIR T1 mapping), including a subset of patients with AF (n = 28) with low CHA2 DS2-VASc score (0/1 for men/women). Conclusion: Study results suggest that an LV ECV expansion is not associated with AF or AF-mediated LVSD.

Original languageEnglish (US)
Article numbere190096
JournalRadiology: Cardiothoracic Imaging
Volume2
Issue number2
DOIs
StatePublished - Apr 2020

Funding

This study was supported by the National Institutes of Health (grants R01HL116895, R01HL138578, R21EB024315, and R21AG055954) and American Heart Association (grants 14SFRN20480260 and 19IPLOI34760317). Acknowledgments: The authors thank funding support from the National Institutes of Health (R01HL116895, R01HL138578, R21EB024315, and R21AG055954) and American Heart Association (14SFRN20480260 and 19IPLOI34760317).

Keywords

  • Adults
  • Cardiac
  • Cardiomyopathies
  • Experimental investigations
  • Heart
  • Left ventricle
  • MR-Imaging
  • Pulmonary vein isolation or ablation (PVI)
  • Technology assessment

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Left ventricular extracellular volume expansion is not associated with atrial fibrillation or atrial fibrillation– Mediated left ventricular systolic dysfunction'. Together they form a unique fingerprint.

Cite this